Skip to main content

Table 6 Fertilisation, embryo development and outcome in the ANA + cycles without P + A and the ANA + cycles with P + A

From: A retrospective study on IVF/ICSI outcome in patients with anti-nuclear antibodies: the effects of prednisone plus low-dose aspirin adjuvant treatment

Variables Without P + A With P + A P
OPU cycles (IVF + ICSI) 21(11 + 10) 21 (11 + 10) -
ET cycles 16 21 -
Semen volume (ml, ICSI cycles) 3.54+/-0.81 3.09+/-0.87 ns
Sperm concentration (×106/ml, ICSI cycles) 14.64+/-11.21 16.34+/-10.65 ns
Sperm progressive motility (%, ICSI cycles) 12.87+/-10.97 15.34+/-11.56 ns
Semen volume (ml, IVF cycles) 3.44+/-0.93 3.64+/-0.83 ns
Sperm concentration (×106/ml, IVF cycles) 62.56+/-43.78 66.23+/-39.23 ns
Sperm progressive motility (%, IVF cycles) 46.89+/-15.45 43.89+/-17.68 ns
Retrieved oocytes 8.10 +/- 3.95 9.24 +/- 4.10 ns
MII oocytes 6.50 +/- 4.09 7.20 +/- 3.99 ns
Two pro-nuclei 4.86 +/- 2.89 7.05 +/- 3.17 0.004
Perfect embryos 3.24 +/- 2.41 4.76 +/- 2.93 0.037
Available embryos 3.62 +/- 2.22 5.76 +/- 3.25 0.008
Embryos 4.81 +/- 2.93 6.90 +/- 3.24 0.006
Transferred embryos/cycle 2.06 +/- 0.44 2.76 +/- 0.58 0.008
Pregnancy rate (%) 12.5 (2/16) 57.1% (12/21) 0.006
Implantation rate (%) 6.06 (2/33) 27.9 (16/58) 0.013
Early miscarriage rate (%) 100 (2/2) 25 (3/12) -
  1. P < 0.05 was considered to be statistically significant.